Search Results - Klimak, P.

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)

    Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or m... by Ruzsa, A., Sen, M., Evans, M., Lee, L. W., Hideghety, K., Rottey, S., Klimak, P., Holeckova, P., Fayette, J., Csoszi, T., Erfan, J., Forssmann, U., Goddemeier, T., Bexon, A., Nutting, C.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Ultrasmall cationic superparamagnetic iron oxide nanoparticles as nontoxic and efficient MRI contrast agent and magnetic-targeting tool

    Ultrasmall cationic superparamagnetic iron oxide nanoparticles as nontoxic and efficient MRI contrast agent and magnetic-targeting tool by Uchiyama, Mayara Klimuk, Toma, Sergio Hiroshi, Rodrigues, Stephen Fernandes de Paula, Shimada, Ana Lucia Borges, Loiola, Rodrigo Azevedo, Cervantes Rodríguez, Hernán Joel, Oliveira, Pedro Vitoriano, Luz, Maciel Santos, Rabbani, Said Rahnamaye, Toma, Henrique Eisi, Poliselli Farsky, Sandra Helena, Araki, Koiti

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: